JPRN-UMIN000004399已完成未知
Effect of raloxifene on bone metabolism, lipid profile and glucose metabolism in postmenopausal women with type 2 diabetes mellitus - Effect of raloxifene on bone metabolism, lipid profile, and glucose metabolism in postmenopausal women with type 2 diabetes mellitus
niversity of Occupational and Environmental Health, Japan0 个研究点目标入组 150 人开始时间: 2010年12月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 80years-old（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •(1)history of phlebothrombosis (2) bed-ridden people (3)Anti-phospholipid antibody syndrome; (4)history of hypersensitivity to raloxifene or alfacalcidol (5)With effective drug of bone metabolism(bisphosphonates, vitaminK, estrogen, calcium, anabolic steroid, sex hormones)
研究者
相似试验
已完成
4 期
Long Term Effects of Raloxifene Treatment on Bone QualityOsteoporosis, Post-MenopausalNCT00532428Eli Lilly and Company31
已完成
4 期
Effect of Raloxifene Plus Cholecalciferol and Cholecalciferol Alone on the Bone Mineral Density in Postmenopausal Women With OsteopeniaPostemenopusal Women With OsteopeniaNCT05386784Yonsei University112
已完成
3 期
Effects of Arzoxifene on Bone Mass and the UterusPostmenopausal Bone LossNCT00085956Eli Lilly and Company300
招募中
不适用
Effects of Eldecalcitol and Raloxifene on the suppression of new vertebral fracture with osteoporosis in perimenopausal women or ovariectomy patients: Randomized controlled trialosteoporosis in perimenopausal women or ovariectomy patientsJPRN-UMIN000009378Tokyo Women's Medical University Hospital360
已完成
4 期
Raloxifene for Prevention of Bone Loss in Postmenopausal Patients Receiving Chronic Corticosteroid TherapyOsteoporosisNCT00371956Tuen Mun Hospital114